Shape Biopharmaceuticals GmbH 

Shape Biopharmaceuticals specialises in the development of innovative immunotherapies based on nanoparticles. The nanomedicines are intended to help patients for whom there are currently no therapies for chronic diseases or forms of cancer. The nanomedicines change the immune system so that it produces antibodies and can fight the disease. Shape combines expertise in immunobiology, chemistry and medicine with state-of-the-art technologies for computer-aided protein design and nanoparticle engineering. Shape has sites in Cambridge, Massachusetts (USA) and in the Canton of Zurich, Switzerland.